Mankind Pharma Limited (NSE:MANKIND)

Market Cap	970.77B
Revenue (ttm)	122.07B
Net Income (ttm)	19.91B
Shares Out	412.67M
EPS (ttm)	49.20
PE Ratio	47.92
Forward PE	46.30
Dividend	n/a
Ex-Dividend Date	n/a

Volume	353,197
Average Volume	347,416
Open	2,370.00
Previous Close	2,359.20
Day's Range	2,345.90 - 2,379.90
52-Week Range	1,901.05 - 3,054.80
Beta	0.49
RSI	37.92
Earnings Date	May 15, 2025

About Mankind Pharma

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and m...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 19,540
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MANKIND

Financial Performance

In 2024, Mankind Pharma's revenue was 122.07 billion, an increase of 18.12% compared to the previous year's 103.35 billion. Earnings were 19.91 billion, an increase of 4.08%.